共 6 条
[1]
Coronary stent restenosis in patients treated with cilostazol
[J].
CIRCULATION,
2005, 112 (18)
:2826-2832
[2]
RACTS: A Prospective Randomized Antiplatelet Trial of Cilostazol Versus Ticlopidine in Patients Undergoing Coronary Stenting: Long-Term Clinical and Angiographic Outcome[J] . Junbo Ge,Yaling Han,Hong Jiang,Baogui Sun,Jiyan Chen,Shuyang Zhang,Zhimin Du.Journal of Cardiovascular Pharmacology . 2005 (2)
[3]
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study[J] . Basil S. Lewis,Shamir R. Mehta,Keith A.A. Fox,David A. Halon,Feng Zhao,Ron J.G. Peters,Matyas Keltai,Andrzej Budaj,Salim Yusuf.American Heart Journal . 2005 (6)
[5]
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents[J] . Alison L. Calver,Lucy J. Blows,Sue Harmer,Keith D. Dawkins,Huon H. Gray,John H. Morgan,Iain A. Simpson.American Heart Journal . 2000 (3)
[6]
MK-383 (L-700,462), a Selective Nonpeptide Platelet Glycoprotein 1Ib/IIIa Antagonist, Is Active in Man[J] . K. Peerlinck,I. De Lepeleire,M. Goldberg,D. Farrell,J. Barrett,E. Hand,D. Panebianco,H. Deckmyn,J. Vermylen,J. Arnout.Circulation . 1993 (4, P)